Essentials: Compulsive Behaviors & Deep Brain Stimulation | Dr. Casey Halpern

DBS involves implanting thin wires into specific brain regions to deliver electrical stimulation. While primarily used for movement disorders like Parkinson's, it has shown therapeutic effects on psychiatric comorbidities such as depression and OCD, often discovered serendipitously when patients reported improvements in gambling issues or mood.

Dr. Halpern describes how DBS for Parkinson's patients can sometimes 'melt away' psychiatric problems, leading to the exploration of DBS for conditions like OCD. He notes the immediate relief of tremor seen with DBS as a powerful inspiration for its application to other symptoms.

The nucleus accumbens, part of the brain's reward circuits, is deeply involved in gating reward-seeking behavior. When perturbed, it can drive compulsive actions, where individuals pursue rewards despite significant risks or negative consequences, a common denominator in OCD, addiction, and eating disorders.

Halpern explains that a rat will pursue a reward despite foot shock when this area is perturbed, analogous to an OCD patient checking locks until 3 AM or an addict seeking drugs despite lethal risks. He states, 'If you have an urge for a reward that either puts you or somebody else at risk, it's probably a reward we shouldn't have.'

Transcranial Magnetic Stimulation (TMS) and MRI-guided focused ultrasound are non-invasive techniques gaining traction. TMS is FDA-approved for depression, OCD, and nicotine addiction, while focused ultrasound is FDA-approved for tremor and is being explored for its modulatory and ablative potential in psychiatric diseases, offering a less invasive alternative to traditional surgery.

Dr. Halpern notes that TMS is FDA approved for depression, OCD, and nicotine addiction, and focused ultrasound is routinely used for tremor. He expresses hope that these non-invasive methods could eventually target conditions like anorexia and obesity, once precise brain targets are identified through invasive studies.

While improving patient awareness through therapies like CBT is beneficial for less severe cases, many refractory patients cannot control their compulsions despite full awareness. Future solutions may involve machine learning and AI to anticipate impulsive episodes (like suicidal thinking or binge eating) by analyzing physiological cues, offering predictive interventions.

Halpern describes lab studies where patients, fully aware they are being studied, still binge, indicating a lack of control despite awareness. He discusses the potential for AI to detect patterns in voice, breathing, and sleep to predict impulsive episodes, similar to how search algorithms predict preferences, to provide 'yellow light' warnings.